Position history for CAPITAL FUND MANAGEMENT S.A.'s holdings in PROTAGONIST THERAPEUTICS INC
CAPITAL FUND MANAGEMENT S.A. previously held 0 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $0 as of 2025-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$1.1M
Total Shares Change
-28,058
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BlackRock, Inc.
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $87.26 |
0 |
| 2025-Q3 | Decreased | 20,348 | -59.1% | $1.4M | 0.0% | $65.14 | 0 |
| 2025-Q2 | New | 49,805 | - | $2.8M | 0.0% | $55.69 | 36 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $48.88 | 0 |
| 2024-Q4 | New | 28,058 | - | $1.1M | 0.0% | $38.51 | 35 |